Pierangeli et al showed the pathogenic potential of IgA in a murine model [179] and proposed the potential for IgA aβ2GPI positive patients to develop APS even in the absence of IgG and IgM aβ2GPI. Here, CD79A is linked to autoimmune polyendocrinopathy.